FDA Gives Leqembi Full Approval
On July 6th, 2023, the U.S. Food and Drug Administration (FDA) made history by granting the full traditional approval for the use of...
top of page
Search
outreach1412
- Jun 15
- 1 min
Clinical Research is for Everyone!
--> JUNE PODCAST <-- June is the month that we celebrate uniqueness in humanity. Whether we're at an LGBTQ+ Pride festival or a...
49 views0 comments
outreach1412
- May 17
- 1 min
Dr. William Alford's Research creates Major breakthrough in Women's Health
Neuro-Behavioral Clinical Research would like to congratulate our partners at Astrellas on the approval of VEOZAHâ„¢ (fezolinetant) by the...
62 views0 comments
outreach1412
- May 1
- 2 min
Psychedelic-Assisted Therapy: Truth or Trip?
Popular films & media are littered with references to psychedelic use. These powerful compounds have been used for centuries, claiming to...
127 views0 comments
outreach1412
- Mar 1
- 3 min
A Thank You Letter to Women in Research...
Growing up in middle America in the 1980s, Clinical Research was not exactly a hot topic around the local watering holes. The last thing...
82 views0 comments
outreach1412
- Feb 8
- 2 min
Barbershop Talk: The Legend of "Fame City Kut n Kurl"
The name of this write-up is tied to one of the most legendary places in Canton, Ohio! I am not just saying this because this was my...
34 views0 comments
outreach1412
- Feb 8
- 4 min
Cheers To Mental Wellness!
January is Mental Wellness month! Yet, after the holidays people often feel exhausted and far from mentally well. To make matters worse,...
42 views0 comments
neurobehavioralclinicalresearch
- Dec 19, 2022
- 5 min
Cerevel Therapeutics Announces Positive Results in Emraclidine Ambulatory Blood Pressure Monitoring
Data provide clear evidence that emraclidine does not induce an increase in blood pressure with chronic dosing in people living with...
18 views0 comments
neurobehavioralclinicalresearch
- Dec 19, 2022
- 6 min
Fanapt® Shown to be Effective in Bipolar I Disorder in Phase III Clinical Study
Supplemental New Drug Application (sNDA) planned for 2023 WASHINGTON, Dec. 19, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda)...
2 views0 comments
neurobehavioralclinicalresearch
- Jun 14, 2021
- 12 min
Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone
At the Day 15 primary endpoint, zuranolone 50 mg showed a statistically significant and clinically meaningful reduction in depressive...
11 views0 comments
bottom of page